Published in Biotech Business Week, February 13th, 2006
In connection with the corporate reorganization, Cardium's former parent, Aries Ventures, Inc., was merged with and into Cardium Therapeutics, Inc., a Delaware corporation. Cardium expects to provide an update shortly regarding its new trading symbol once it has been issued. Cardium also announced the filing of a resale registration statement on Form SB-2 with the U.S. Securities and Exchange Commission, which is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.